European Patent Office turns its back on EU decisions
- Details
EPO practice of allowing patents on non-GM plants is becoming increasingly brazen, says No Patents on Seeds
Recent decisions by the European Patent Office (EPO) show that existing bans on the patenting of seeds are insufficient to stop the monopolisation of natural genetic resources, reports No Patents on Seeds! The group says despite the ban on patenting plants obtained from “essentially biological processes” (also known as Rule 28(2) of the European Patent Convention), naturally occurring plant genes continue to be patented as inventions. As a result, plants bred on the basis of these genes also fall within the scope of the patents.
Examples of patents granted in 2025 claiming naturally occurring genes include spinach (EP3975697), tomatoes (EP3911147) and lettuce (EP3797582). For example, a patent granted to Bayer claims natural gene variants which supposedly make lettuce resistant to certain aphids. The patent was granted in December 2025.
Under existing patent law, the scope of patents claiming genes also extends to all plants that are bred using the patented genes (Article 9 of EU Patent Directive 98/44). This means that even plants obtained from simple crossbreeding can be covered by patents, despite the EU having made it clear in 2017 that these are not patentable. The EPO does not directly patent the plants but does allow claims on naturally occurring gene variants that extend to the plants.
According to EU law, patents can only be granted on genes that are isolated from their natural environment. The original intention of the legislator was to only permit patents on genetic engineering methods. However, a recent EPO decision regarding an opposition filed against a patent on maize granted to KWS (EP3560330), shows that the EPO considers genes to be patentable even in cases of conventional breeding.
These patents are a major problem, especially for small and medium-sized traditional breeding companies, as they are often unable to pay expensive license fees or hire patent attorneys. As a result, breeding projects have had to be abandoned. A recent EU Commission report acknowledged that these problems do exist.
In the discussion on the future EU regulation of plants obtained from new genetic engineering (NGT), the EU Parliament proposed at minimum banning patents on conventional plant breeding and naturally occurring gene variants. However, these demands are no longer included in the current draft text negotiated in December 2025. Therefore, No Patents on Seeds! urges the EU Parliament to reject this proposal and to enforce the current prohibitions in patent law through effective regulation.
Further information
The maize patent of KWS
Report on patents granted in 2025
Source: No Patents on Seeds!
Images: Shutterstock (licensed purchases)
Scientist, farmer, and campaigner all call time on glyphosate
- Details
Pre-harvest desiccation and non-farming uses of glyphosate should be banned, conference speakers agree. Report: Claire Robinson
Now the European Parliament must save GM labelling – GMO-free industry association
- Details
"Germany did not agree to the ill-conceived and economically and consumer-damaging abolition of mandatory GMO labelling in the EU" – VLOG
Holiday revelation: Wild American chestnuts thriving on biologist’s land in Maine
- Details
Film gives the lie to claims by some researchers that genetically engineered trees are the only path to restoration of the American chestnut
EU governments sign off on far-reaching GMO deregulation
- Details
"Most EU governments want to allow untested and unlabelled GM plants to be released into the environment and onto our plates" – Save Our Seeds
EU Member States approve the deregulation of GMOs obtained by new GM techniques
- Details
European Coordination Via Campesina (ECVC) denounces "strategic error for Europe’s food and seed sovereignty"
Gene editing disrupts multiple gene functions through large-scale epigenetic changes in a way that persists through successive cell generations
- Details
Study finds CRISPR/Cas gene editing causes “chromatin fatigue” – another surprise mechanism by which it can produce unwanted changes in gene function. Report: Claire Robinson and Prof Michael Antoniou
Faking it without making it: The de-extinction disinfo campaign manager’s history of hype
- Details
How Colossal Biosciences’ CEO Ben Lamm keeps the hype cycle going. By Jonathan Matthews
Journal finally retracts Roundup cancer study reliant on Monsanto research and ghostwriting
- Details
“Now that much of the research finding glyphosate poses no cancer risk has been undermined, it is especially outrageous that the Trump administration is seeking to bolster Bayer’s case,” said one campaigner. By Jessica Corbett
Comments on provisional new GMOs legislation that abandons risk assessment, labelling and traceability
- Details
ENGA (the European Non-GMO Industry Association) and Friends of the Earth Europe denounced the deal
Bad deal reached on new GMO deregulation file in EU trilogue
- Details
No risk assessment, traceability or labelling for 94% of new GMOs; rapporteur betrays intent of Parliament
Silicon Valley’s race to produce genetically engineered humans
- Details
By Katie Hasson, Biopolitical Times
IUCN votes on gene editing in conservation: Biotech lobbyists ‘win’, nature loses
- Details
Report by Beyond GM
US tech billionaire pumps $60 million into British firm to develop GM crops and AI
- Details
Larry Ellison is also a major funder of the Tony Blair Institute, which cheerleads for GM and AI. Report: Claire Robinson and Jonathan Matthews
EU deregulation of genetic engineering: Parliament's mandate at risk of being disregarded
- Details
Green MEP Martin Häusling warns that the Parliament's rapporteur is going rogue in her support for deregulation
The limits and dangers of genetic engineering in agriculture
- Details
Dr Million Belay interviews molecular geneticist Prof Michael Antoniou
Oxitec withdraws application to release its GM mosquitoes in Australia
- Details
GM mozzies plan had attracted strong opposition from the public and scientists
Patent on maize with native traits upheld
- Details
Precedent case shows new rule does not solve problems
Poll: 82% of Danes oppose GMO deregulation, at odds with government position
- Details
Poll comes as EU institutions are in the final negotiation rounds to determine if new GMO products will be exempt from labelling and traceability requirements
Victory! Center for Food Safety secures win for the public’s right to know in GMO labelling lawsuit
- Details
Court says USDA's labelling exemption for “highly refined” or ultra-processed GMO foods — such as corn and soy oils — is unlawful
Dark PR attacks on critics of 10-billion-dollar biotech Goliath
- Details
Debunkers of de-extinction disinformation hit by vicious campaign of intimidation. Report: Jonathan Matthews
Long-read whole genome sequencing the only way to confirm absence of foreign DNA in gene-edited products
- Details
New scientific article warns of loss of consumer trust unless proper analysis is done. Report: Claire Robinson
No “undo button” for nature: IUCN must say no to genetically engineered wild species
- Details
Over 90 NGOs urge moratorium on genetic engineering in the wild as World Conservation Congress meets in Abu Dhabi
New GMOs exacerbate patent thicket for farmers and breeders
- Details
ARCHE NOAH briefing shows that EU institutions have the legal power to act
Scientific publication on AI-designed "new GMO" maize
- Details
The EU Commission would allow the release of the plants without prior risk assessment










